Tirzepatide may also be prescribed among individuals who are overweight, with a BMI of 27 or higher, if they have other health issues that are associated with their being overweight
Meanwhile other research has shown that our GLP-1 levels may be closely linked to our gut microbiome [1,2]
This was a landmark finding because it established that a weight loss medication could provide cardiovascular protection independent of diabetes status
Patients with a history of allergic reactions or sensitivities to GLP-1 receptor agonists, pancreatitis, thyroid cancerincluding medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN-2) generally are not suitable candidates for this therapy
hormone-based metabolic understanding
It may help lower blood pressure as part of weight loss and metabolic improvement, but high blood pressure should still be managed with medical guidance